A key component of the CNTM research is developing preclinical disease models, which allow direct translation to the patient applications. These range from in vivo models of complex disease to next generation human organoid 3D models. With these capabilities, the Centre and its researchers are involved in numerous projects with health and clinical partners, such as the NHS and Cancer Research UK, to bring these new technologies to the medical frontline.